Ironwood Pharmaceuticals (IRWD) Appoints Lawrence Olanoff, M.D., Ph.D., To Board Of Directors

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today the appointment of Lawrence Olanoff, M.D., Ph.D., to its board of directors as well as to its pharmaceutical advisory committee. Dr. Olanoff has more than 30 years of pharmaceutical industry experience and has been a leader in clinical development, discovery research, strategy and operations for several companies ranging from small biotechnology firms to large pharmaceutical corporations. Most recently, he served as a director and as chief operating officer of Forest Laboratories, Inc.

Suggested Articles

After beating the standard of care at keeping testosterone levels down, Myovant's prostate cancer drug fell short in patients with metastatic disease.

A Mount Sinai-led team found that immune cells in the brain protect it from abnormal activation that can lead to behavioral problems.

Results from the small cohort suggest the vaccine triggers comparable immune responses in younger and older adults.